ID

12789

Description

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00726934

Link

https://clinicaltrials.gov/show/NCT00726934

Keywords

Versions (1)
  1. 12/21/15 12/21/15 -
Uploaded on

December 21, 2015

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Acute Lymphoblastic Leukemia NCT00726934

English

Eligibility Acute Lymphoblastic Leukemia NCT00726934

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients between the ages of 1 and 30 years with:
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
acute lymphoblastic leukemia/lymphoma
Description

acute lymphoblastic leukemia/lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0023449
UMLS CUI [2]
C0024299
malignant brain tumor
Description

malignant brain tumor

Data type

boolean

Alias
UMLS CUI [1]
C0153633
non-cns solid tumors
Description

non-cns solid tumors

Data type

boolean

Alias
UMLS CUI [1]
C0280100
acute myeloblastic leukemia
Description

aml

Data type

boolean

Alias
UMLS CUI [1]
C0023467
non-hodgkin's lymphoma hodgkin's disease
Description

nhl

Data type

boolean

Alias
UMLS CUI [1]
C0024305
head and neck tumors
Description

head and neck tumors

Data type

boolean

Alias
UMLS CUI [1]
C0018671
patients must also be ready to receive a cycle of chemotherapy that predictably renders neutropenia at least 70 percent of the time or has a risk of febrile neutropenia of at least 20 percent. this can be any cycle number, it does not need to be the first cycle of chemotherapy they are to receive.
Description

patients must also be ready to receive a cycle of chemotherapy that predictably renders neutropenia

Data type

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0027947
UMLS CUI [3]
C0746883
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients receiving myeloablative chemotherapy in preparation for allogeneic or autologous bone marrow or stem cell transplant.
Description

patients receiving myeloablative chemotherapy in preparation for allogeneic or autologous bone marrow or stem cell transplant

Data type

boolean

Alias
UMLS CUI [1]
C0194037
UMLS CUI [2]
C1504389
co-morbidity with immunosuppressive disease such as aids.
Description

aids

Data type

boolean

Alias
UMLS CUI [1]
C0001175
asplenia.
Description

asplenia

Data type

boolean

Alias
UMLS CUI [1]
C3810472
patients with documented infection at time of enrollment.
Description

infection

Data type

boolean

Alias
UMLS CUI [1]
C0009450
patients who are not fed orally (g-tube dependant, tpn-dependant).
Description

artificial nutrition

Data type

boolean

Alias
UMLS CUI [1]
C3845548
patients actively receiving radiation to the brain or gastrointestinal tract for sarcoma.
Description

radiotherapy

Data type

boolean

Alias
UMLS CUI [1]
C1522449
Back to the top of the page

Similar models

Eligibility Acute Lymphoblastic Leukemia NCT00726934

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
patients between the ages of 1 and 30 years with:
boolean
C0001779 (UMLS CUI [1])
acute lymphoblastic leukemia/lymphoma
Item
acute lymphoblastic leukemia/lymphoma
boolean
C0023449 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
malignant brain tumor
Item
malignant brain tumor
boolean
C0153633 (UMLS CUI [1])
non-cns solid tumors
Item
non-cns solid tumors
boolean
C0280100 (UMLS CUI [1])
aml
Item
acute myeloblastic leukemia
boolean
C0023467 (UMLS CUI [1])
nhl
Item
non-hodgkin's lymphoma hodgkin's disease
boolean
C0024305 (UMLS CUI [1])
head and neck tumors
Item
head and neck tumors
boolean
C0018671 (UMLS CUI [1])
patients must also be ready to receive a cycle of chemotherapy that predictably renders neutropenia
Item
patients must also be ready to receive a cycle of chemotherapy that predictably renders neutropenia at least 70 percent of the time or has a risk of febrile neutropenia of at least 20 percent. this can be any cycle number, it does not need to be the first cycle of chemotherapy they are to receive.
boolean
C0392920 (UMLS CUI [1])
C0027947 (UMLS CUI [2])
C0746883 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
patients receiving myeloablative chemotherapy in preparation for allogeneic or autologous bone marrow or stem cell transplant
Item
patients receiving myeloablative chemotherapy in preparation for allogeneic or autologous bone marrow or stem cell transplant.
boolean
C0194037 (UMLS CUI [1])
C1504389 (UMLS CUI [2])
aids
Item
co-morbidity with immunosuppressive disease such as aids.
boolean
C0001175 (UMLS CUI [1])
asplenia
Item
asplenia.
boolean
C3810472 (UMLS CUI [1])
infection
Item
patients with documented infection at time of enrollment.
boolean
C0009450 (UMLS CUI [1])
artificial nutrition
Item
patients who are not fed orally (g-tube dependant, tpn-dependant).
boolean
C3845548 (UMLS CUI [1])
radiotherapy
Item
patients actively receiving radiation to the brain or gastrointestinal tract for sarcoma.
boolean
C1522449 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial